Oster, H. and Mittelman, M. (2020) “Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300405.